“…Several prospective randomized studies in adults with high-risk glaucoma filtering surgery have shown that intraoperative MMC may be a better alternative to the use of postoperative 5-FU because MMC-augmented trabeculectomy is shown to have resulted in lower overall IOP, decreased dependence on postoperative antiglaucoma medication, and decreased corneal toxicity. [31][32][33] Khaw et al, 34 in an elegant study of cell culture analysis, demonstrated the greater effect of MMC as compared to 5-FU on both fibroblast proliferation and morphologic characteristics. Encouraging reports of intraoperative use of MMC in adults, [31][32][33] coupled with the difficulties encountered by repeated injections of 5-FU in children, prompted us to use MMC intraoperatively during glaucoma filtering surgery in these patients.…”